PolyActiva Pty Ltd, a clinical-stage Australian biotechnology company, has recently recruited first patients into its Phase I clinical study designed to show its glaucoma implant is safe and well tolerated…

PolyActiva announced today that it has raised AUD $9.2 Million in a Series B financing round from a consortium of investors including the Medical Research Commercialisation Fund (MRCF) and Brandon Biosciences Fund 1 (BBF1) (both managed by Brandon Capital), Yuuwa Capital and additional participation from angel investors.

Victorian Minister for Technology Gordon Rich-Phillips today announced new funding of $1.6 million from the Victorian Government to support the operation of the Medical Research Commercialisation Fund (MRCF) over the next four years.  An example of an innovative business benefiting from the MRCF is PolyActiva…